UA105425C2 - Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения - Google Patents

Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения

Info

Publication number
UA105425C2
UA105425C2 UAA201211720A UAA201211720A UA105425C2 UA 105425 C2 UA105425 C2 UA 105425C2 UA A201211720 A UAA201211720 A UA A201211720A UA A201211720 A UAA201211720 A UA A201211720A UA 105425 C2 UA105425 C2 UA 105425C2
Authority
UA
Ukraine
Prior art keywords
preparation
crystal form
agomelatine
hydrobromide hydrate
hydrate
Prior art date
Application number
UAA201211720A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ханбин Шан
Жедонг Йуан
Ксуеян Жу
Пенг Жанг
Хонгджуан Пан
Ксионг Йу
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44599556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA105425(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA105425C2 publication Critical patent/UA105425C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Данное изобретение касается агомелатина гидрохлорида гидрата формулы I, его приготовления и применения, а также фармацевтической композиции, которая его содержит. Агомелатина гидрохлорида гидрат, полученный с помощью данного способа, имеет значительно повышенную растворимость по сравнению с агомелатином и поэтому более пригодный для изготовления фармацевтических лекарственных средств. Кроме того, продукт имеет более высокую стабильностью и чистоту.Используя данный способ, продукт высокой чистоты может быть получен с помощью простого процесса, без любых сложных шагов, (I)где X представляет собой Cl.
UAA201211720A 2010-03-17 2011-03-17 Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения UA105425C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010126254XA CN102190594A (zh) 2010-03-17 2010-03-17 阿戈美拉汀氯化氢水合物及其制备方法
PCT/CN2011/071910 WO2011113362A1 (en) 2010-03-17 2011-03-17 Agomelatine hydrochloride hydrate and preparation thereof

Publications (1)

Publication Number Publication Date
UA105425C2 true UA105425C2 (ru) 2014-05-12

Family

ID=44599556

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201211720A UA105425C2 (ru) 2010-03-17 2011-03-17 Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения

Country Status (36)

Country Link
US (1) US8729131B2 (ru)
EP (1) EP2547649B1 (ru)
JP (1) JP5634532B2 (ru)
KR (1) KR101406727B1 (ru)
CN (2) CN102190594A (ru)
AP (1) AP2012006492A0 (ru)
AU (1) AU2011229618B2 (ru)
BR (1) BR112012023317B1 (ru)
CA (1) CA2792417C (ru)
CL (1) CL2012002540A1 (ru)
CR (1) CR20120462A (ru)
CU (1) CU20120137A7 (ru)
CY (1) CY1116086T1 (ru)
DK (1) DK2547649T3 (ru)
EA (1) EA022067B1 (ru)
EC (1) ECSP12012155A (ru)
ES (1) ES2530772T3 (ru)
GE (1) GEP20156231B (ru)
GT (1) GT201200259A (ru)
HK (1) HK1177451A1 (ru)
HR (1) HRP20150071T1 (ru)
IL (1) IL221782A (ru)
MA (1) MA34055B1 (ru)
ME (1) ME02054B (ru)
MX (1) MX2012010541A (ru)
NI (1) NI201200140A (ru)
NZ (1) NZ602450A (ru)
PE (1) PE20130013A1 (ru)
PL (1) PL2547649T3 (ru)
PT (1) PT2547649E (ru)
RS (1) RS53815B1 (ru)
SG (1) SG183868A1 (ru)
SI (1) SI2547649T1 (ru)
TN (1) TN2012000435A1 (ru)
UA (1) UA105425C2 (ru)
WO (1) WO2011113362A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2551257A1 (en) * 2011-07-28 2013-01-30 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of agomelatine with co-crystal-formers
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013170738A1 (zh) * 2012-05-14 2013-11-21 上海右手医药科技开发有限公司 阿戈美拉汀酸根复合物及其制备方法和用途
CN102702041B (zh) * 2012-05-14 2013-08-14 上海右手医药科技开发有限公司 阿戈美拉汀苯磺酸类复合物及其制备方法
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
CN102718676B (zh) * 2012-06-26 2014-04-09 福建广生堂药业股份有限公司 阿戈美拉汀硫酸盐及其制备方法
EP2934502A1 (en) 2012-12-21 2015-10-28 Laboratorios Lesvi S.L. Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2015013865A1 (en) * 2013-07-29 2015-02-05 Les Laboratoires Servier Agomelatine sulfonic acids complexes and preparation thereof
KR101470794B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물
MA50817B1 (fr) 2015-07-02 2021-10-29 Acerta Pharma Bv Formes et formulations solides de (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
US10367757B2 (en) * 2016-08-27 2019-07-30 Nicira, Inc. Extension of network control system into public cloud

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
PL366150A1 (en) * 2000-10-30 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
FR2934859B1 (fr) * 2008-08-05 2010-08-13 Servier Lab Nouveau procede de synthese de l'agomelatine
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms

Also Published As

Publication number Publication date
KR20120128712A (ko) 2012-11-27
PL2547649T3 (pl) 2015-04-30
SG183868A1 (en) 2012-10-30
BR112012023317B1 (pt) 2021-07-06
AP2012006492A0 (en) 2012-10-31
BR112012023317A2 (pt) 2016-05-24
PE20130013A1 (es) 2013-01-26
MX2012010541A (es) 2012-10-05
CY1116086T1 (el) 2017-02-08
SI2547649T1 (sl) 2015-03-31
ME02054B (me) 2015-05-20
NZ602450A (en) 2014-12-24
CN102190594A (zh) 2011-09-21
CL2012002540A1 (es) 2013-01-11
NI201200140A (es) 2012-11-09
EP2547649A1 (en) 2013-01-23
CN102958911B (zh) 2015-11-25
KR101406727B1 (ko) 2014-06-13
RS53815B1 (en) 2015-06-30
CA2792417A1 (en) 2011-09-22
EP2547649A4 (en) 2013-09-04
GT201200259A (es) 2013-12-03
EA022067B1 (ru) 2015-10-30
ECSP12012155A (es) 2012-12-28
JP2013522241A (ja) 2013-06-13
EP2547649B1 (en) 2014-11-19
CA2792417C (en) 2015-11-24
CU20120137A7 (es) 2012-11-15
CR20120462A (es) 2012-10-05
US20130005820A1 (en) 2013-01-03
ES2530772T3 (es) 2015-03-05
IL221782A (en) 2017-11-30
EA201201294A1 (ru) 2013-04-30
CN102958911A (zh) 2013-03-06
DK2547649T3 (en) 2015-03-02
JP5634532B2 (ja) 2014-12-03
US8729131B2 (en) 2014-05-20
MA34055B1 (fr) 2013-03-05
AU2011229618B2 (en) 2014-05-22
HRP20150071T1 (en) 2015-02-27
AU2011229618A1 (en) 2012-09-27
TN2012000435A1 (en) 2014-01-30
HK1177451A1 (zh) 2013-08-23
WO2011113362A1 (en) 2011-09-22
PT2547649E (pt) 2014-12-29
GEP20156231B (en) 2015-01-26

Similar Documents

Publication Publication Date Title
UA105425C2 (ru) Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения
MY160460A (en) Agomelatine hydrochloride hydrate and preparation thereof
MX2011008946A (es) Un complejo de haluro de hidrogeno de agomelatina y la preparacion del mismo.
MD20140072A2 (ru) Новые пиррольные соединения, способ их получения и содержащие их фармацевтические композиции
MX2022003486A (es) Composiciones terapeuticas de ceramidasa acida y metodos para prepararlas y utilizarlas.
MX2012008413A (es) Composicion novedosa de retigabina.
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
TN2012000436A1 (en) Agomelatine hydrobromide hydrate and preparation thereof
MX2010001512A (es) Nuevo procedimiento de preparacion.
IN2014DN10658A (ru)
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
UA116994C2 (uk) Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять
JO3276B1 (ar) طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.
NZ630795A (en) Crystalline form of vsn16
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
GB2498107A (en) Crystalline form of prulifloxacin and processes for its preparation
CO6551663A2 (es) Hodrato del hidrocloruro de agomelatina y preparacion de este
TN2011000425A1 (en) Agomelatine hydrohalide complex and preparation method thereof
RO127619A8 (ro) Derivat naftalendionic utilizat în controlul creşterii tumorale